KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Exchange Rate Effect (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Exchange Rate Effect for 12 consecutive years, with -$413000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 57.16% year-over-year to -$413000.0, compared with a TTM value of $2.3 million through Dec 2025, up 350.93%, and an annual FY2025 reading of $2.3 million, up 350.93% over the prior year.
  • Exchange Rate Effect was -$413000.0 for Q4 2025 at Travere Therapeutics, down from $207000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.9 million in Q2 2025 and bottomed at -$1.7 million in Q2 2022.
  • Average Exchange Rate Effect over 5 years is $113900.0, with a median of $53000.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect tumbled 3085.71% in 2022, then skyrocketed 1888.07% in 2025.
  • Year by year, Exchange Rate Effect stood at $1.7 million in 2021, then tumbled by 33.66% to $1.1 million in 2022, then grew by 7.89% to $1.2 million in 2023, then plummeted by 178.31% to -$964000.0 in 2024, then surged by 57.16% to -$413000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for TVTX at -$413000.0 in Q4 2025, $207000.0 in Q3 2025, and $1.9 million in Q2 2025.